Ovarian Cancer Oncogene Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.

  2012cited by this paper
• Transtumoral targeting enabled by a novel neuropilin-binding peptide

  2012cited by this paper
• Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers.

  2011cited by this paper
• Integrated Genomic Analyses of Ovarian Carcinoma

  2011cited by this paper
• Protein transduction domain delivery of therapeutic macromolecules.

  2011cited by this paper
• Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer

  2011influential reference
• GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

  2011cited by this paper
• Modeling high-grade serous ovarian carcinogenesis from the fallopian tube

  2011cited by this paper
• Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs

  2010cited by this paper
• Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

  2010cited by this paper
• Targeting of drugs and nanoparticles to tumors

  2010cited by this paper
• C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration

  2009influential reference
• Knocking down barriers: advances in siRNA delivery

  2009cited by this paper
• Functional Delivery of siRNA in Mice Using Dendriworms

  2009cited by this paper
• Is anticancer drug development heading in the right direction?

  2009cited by this paper
• Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis

  2009cited by this paper
• Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation

  2009cited by this paper
• HOXA9 is required for survival in human MLL-rearranged acute leukemias.

  2009cited by this paper
• Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer

  2009cited by this paper
• New insights into the pathogenesis of serous ovarian cancer and its clinical impact.

  2008cited by this paper
• Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo

  2008cited by this paper
• Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma.

  2008cited by this paper
• In vivo tumor cell targeting with "click" nanoparticles.

  2008cited by this paper
• In vivo imaging of siRNA delivery and silencing in tumors

  2007cited by this paper
• Silencing of mammalian genes by tetracycline-inducible shRNA expression

  2007cited by this paper
• Integrative genomic approaches identify IKBKE as a breast cancer oncogene.

  2007cited by this paper
• NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells.

  2006influential reference
• Drug penetration in solid tumours

  2006cited by this paper
• Hox regulation of normal and leukemic hematopoietic stem cells

  2005cited by this paper
• Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA

  2005cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper
• Myristoylation of viral and bacterial proteins.

  2004cited by this paper
• Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells.

  2004cited by this paper
• A Genetically Defined Model for Human Ovarian Cancer

  2004influential reference
• Developmental genetics of the female reproductive tract in mammals

  2003cited by this paper
• Transcriptional Regulation during p21 WAF1/CIP1 -induced Apoptosis in Human Ovarian Cancer Cells*

  2002cited by this paper
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

  2001cited by this paper
• Long-circulating and target-specific nanoparticles: theory to practice.

  2001cited by this paper
• Secondary structure and position of the cell-penetrating peptide transportan in SDS micelles as determined by NMR.

  2001cited by this paper
• Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

  1998cited by this paper
• Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins

  1997cited by this paper
• Phage Libraries Displaying Cyclic Peptides with Different Ring Sizes: Ligand Specificities of the RGD-Directed Integrins

  1995cited by this paper

• Beyond Endometriosis Genome-Wide Association Study: From Genomics to Phenomics to the Patient

  2016cites this paper
• Genetics of Endometriosis

  2015cites this paper